Anemia
Conference Coverage
Study: Formula-fed extreme preemies need more iron
It’s time to rethink the guidelines on nutritional supplementation for the most premature babies, researchers said.
Conference Coverage
Alloantibody registry would save lives, money
New research supports establishing a national exchange of alloantibody data, to save lives and cut costs in transfusion medicine.
Conference Coverage
Pricey gene therapy looks cost-effective for SCD
Researchers calculated that a costly new treatment being developed for sickle cell disease (SCD) promises to be worth the price.
Feature
Post Roe, pregnant SCD patients facing “dire” risks
Doctors warn that lost abortion rights put many pregnant patients with sickle cell disease (SCD) in danger.
News from the FDA/CDC
FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemia
The one-time gene therapy represents a potential cure in which functional copies of the mutated gene are inserted into patients’ hematopoietic...
Conference Coverage
Momelotinib hits the mark for deadly bone marrow cancer
Phase-3 study shows superiority to danazol and highlights potential for improving outcomes in anemic myelofibrosis.
Conference Coverage
Anticipation key to tackling perioperative anemia
The U.K. issues its first guidelines for perioperative anemia, to optimize care and maximize outcomes for a condition diagnosed in roughly one-...
Conference Coverage
Rapper sings about living with sickle cell disease
A British rapper known as A Star harnesses his firsthand knowledge of sickle cell disease to educate both health care professionals and the public...
News
FDA approves first drug for rare inherited anemia
First-ever drug for hemolytic anemia has been approved by the Food and Drug Administration.
News
FDA approves first-ever drug for cold agglutinin disease
The first drug to treat a rare anemia has been given the green light by the FDA.
News from the FDA/CDC
Voxelotor for sickle cell anemia now down to 4-year-olds